Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Jabbour, Serge
One or more keywords matched the following items that are connected to Jabbour, Serge
Item TypeName
Concept Blood Glucose
Concept Blood Glucose Self-Monitoring
Academic Article Management of diabetes mellitus in the elderly.
Academic Article Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor dapagliflozin.
Academic Article Hypoglycemia in hospitalized patients treated with antihyperglycemic agents.
Academic Article Accuracy of bedside capillary blood glucose measurements in critically ill patients.
Academic Article A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.
Academic Article SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
Academic Article Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
Academic Article Incidence and severity of pancreatogenic diabetes after pancreatic resection.
Academic Article Durability of response to dapagliflozin: a review of long-term efficacy and safety.
Academic Article Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
Academic Article Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control.
Academic Article Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Academic Article Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Academic Article Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.
Academic Article Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 study.
Academic Article Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.
Academic Article Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52?weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.
Academic Article Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial.
Academic Article Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
Academic Article Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
Academic Article Switching to Tirzepatide 5?mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment.
Academic Article Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.
Academic Article Dapagliflozin in type 2 diabetes: effectiveness across the spectrum of disease and over time.
Search Criteria
  • Blood Glucose